Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

531
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
531
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

627
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
627
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

720
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
720
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

679
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
679

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood Pressure Responses to Dietary Salt in Renin-Deficient Dahl Salt-Sensitive Rats.

American journal of physiology. Renal physiology·2026
Same author

Anti-endothelin receptor A autoantibodies associate with immunovascular risk and activate endothelial signalling in SLE.

Lupus science & medicine·2026
Same author

Implications of sex differences in arginine kinetics for individualized treatment of hypertension.

American journal of hypertension·2026
Same author

Sex differences in the progression of salt-sensitive hypertension in aged Dahl salt-sensitive rats.

American journal of physiology. Regulatory, integrative and comparative physiology·2026
Same author

Nicotine-Mediated Redox and Nitrosative Stress in Cardiorenal Health.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Longitudinal multiorgan transcriptomic atlas of salt-induced hypertension.

JCI insight·2026

Related Experiment Video

Updated: Jun 28, 2025

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

5.8K

Lysine and salt-sensitive hypertension.

Lashodya V Dissanayake1, Oleg Palygin2,3, Alexander Staruschenko1,4,5

  • 1Department of Molecular Pharmacology & Physiology, Morsani College of Medicine, University of South Florida, Tampa, Florida.

Current Opinion in Nephrology and Hypertension
|April 19, 2024
PubMed
Summary

Lysine, an essential amino acid, shows promise in treating salt-sensitive hypertension. Supplementation helps protect kidneys by reducing albumin reabsorption and altering metabolites, offering a potential therapeutic strategy for hypertensive kidney disease.

More Related Videos

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
08:08

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta

Published on: June 10, 2015

11.3K
Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
07:51

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography

Published on: September 22, 2011

28.6K

Related Experiment Videos

Last Updated: Jun 28, 2025

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

5.8K
Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
08:08

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta

Published on: June 10, 2015

11.3K
Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
07:51

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography

Published on: September 22, 2011

28.6K

Area of Science:

  • Nephrology
  • Metabolomics
  • Cardiovascular Medicine

Background:

  • Salt-sensitive (SS) hypertension is a significant health concern associated with kidney damage.
  • Current therapeutic strategies for SS hypertension and related renal complications remain limited.
  • Emerging research explores metabolome modification for managing renal and cardiovascular diseases.

Purpose of the Study:

  • To investigate the protective effects of lysine on the progression of salt-sensitive hypertension.
  • To elucidate the underlying mechanisms of lysine's renoprotective action in SS hypertension.

Main Methods:

  • Administration of lysine in a salt-sensitive rodent model of hypertension.
  • Pilot human studies to assess lysine's effects.
  • Multilevel omics analyses to understand metabolic changes.

Main Results:

  • Lysine administration controlled hypertension progression in SS rodents.
  • Lysine inhibited tubular albumin reabsorption, protecting kidneys from damage in animal and human studies.
  • Omics studies revealed increased lysine conjugation and excretion, leading to beneficial metabolic shifts.

Conclusions:

  • Lysine exerts a dual protective effect on the kidneys in SS hypertension: mechanical flushing of protein and metabolic adaptation.
  • Lysine supplementation demonstrates potential as a therapeutic approach for hypertensive kidney disease.
  • Further clinical research is warranted to validate these findings for therapeutic application.